Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR–ERBB2 pathway

Oncogene(2021)10.1038/s41388-021-01802-9Source: DataRank Database

Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR–ERBB2 pathway is a research paper published in Oncogene (2021). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (46)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Spencer Mehdizadeh ORCID,Akihiko Uchiyama ORCID,Yuta Inoue ORCID,Andrew P. Sawaya ORCID,Andrew M. Overmiller ORCID

Live enrichment

PubMed:33947961 PMC:PMC8159909

Intramural NIH HHS

Grant: Z01 AR041124

Intramural NIH HHS

Grant: ZIA AR041124

National Institutes of Health

Grant: 1ZIAAR041124-21

Regulation Of Epidermal Differentiation

greenLicense: cc-by

repositoryhttps://iris.unimore.it/bitstream/11380/1284408/2/Bajpai%20Onc%202021.pdf

publisherhttps://www.nature.com/articles/s41388-021-01802-9.pdf

publisherhttps://www.nature.com/articles/s41388-021-01802-9

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8159909

Europe_PMChttps://europepmc.org/articles/PMC8159909

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsMice, Inbred C57BLMice, KnockoutHumansMiceCarcinoma, Squamous CellSkin NeoplasmsDisease Models, AnimalTetradecanoylphorbol Acetate9,10-Dimethyl-1,2-benzanthraceneHomeodomain ProteinsTranscription FactorsCarcinogensSurvival RateSignal TransductionAgedFemaleMaleNeoplasm GradingErbB ReceptorsErb-b2 Receptor Tyrosine Kinases

Keywords

MaleSkin Neoplasms9,10-Dimethyl-1,2-benzanthraceneErb-b2 Receptor Tyrosine KinasesArticleMiceAnimalsHumansAgedHomeodomain ProteinsMice, KnockoutErbB ReceptorsMice, Inbred C57BLSurvival RateDisease Models, Animal9,10-Dimethyl-1,2-benzanthracene; Aged; Animals; Carcinogens; Carcinoma, Squamous Cell; Disease Models, Animal; ErbB Receptors; Female; Homeodomain Proteins; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Grading; Receptor, ErbB-2; Signal Transduction; Skin Neoplasms; Survival Rate; Tetradecanoylphorbol Acetate; Transcription FactorsCarcinogensCarcinoma, Squamous CellTetradecanoylphorbol AcetateFemaleNeoplasm GradingSignal Transduction

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes

10.6084/m9.figshare.26603953.v1figshare

Additional file 1 of CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes

10.6084/m9.figshare.26603953figshare

Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR–ERBB2 pathway

FAIR Checklist

Authors (14)

Funding (3 grants)

Open Access

Topics

Linked Datasets (2)

Annotations (Europe PMC)